Analysis of HERV-K (HML2) Expression in Colorectal Cancer Samples.
Saved in:
| Title: | Analysis of HERV-K (HML2) Expression in Colorectal Cancer Samples. |
|---|---|
| Authors: | Obrezanenko VS; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Shulga PM; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Volkova AG; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Primova AA; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Remizova YA; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Meshkov IO; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Kikot AD; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Tarasova DA; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Bolashova ES; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Ivashechkin AA; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Makhotenko AV; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Snigir EA; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Masyukova YA; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Radion EI; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Kuznetsova OA; Federal State Budgetary Institution 'NN Blokhin National Medical Research Center of Oncology', Ministry of Health of the Russian Federation (NN Blokhin NMRCO), Moscow 115478, Russia., Cheporova MS; Federal State Budgetary Institution 'NN Blokhin National Medical Research Center of Oncology', Ministry of Health of the Russian Federation (NN Blokhin NMRCO), Moscow 115478, Russia., Fedyanin MY; Federal State Budgetary Institution 'NN Blokhin National Medical Research Center of Oncology', Ministry of Health of the Russian Federation (NN Blokhin NMRCO), Moscow 115478, Russia., Tryakin AA; Federal State Budgetary Institution 'NN Blokhin National Medical Research Center of Oncology', Ministry of Health of the Russian Federation (NN Blokhin NMRCO), Moscow 115478, Russia., Makarov VV; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Yudin VS; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Keskinov AA; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia., Makarova AS; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia. |
| Source: | Epigenomes [Epigenomes] 2026 Feb 12; Vol. 10 (1). Date of Electronic Publication: 2026 Feb 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101736595 Publication Model: Electronic Cited Medium: Internet ISSN: 2075-4655 (Electronic) Linking ISSN: 20754655 NLM ISO Abbreviation: Epigenomes Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41718409 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Analysis of HERV-K (HML2) Expression in Colorectal Cancer Samples. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Obrezanenko+VS%22">Obrezanenko VS</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Shulga+PM%22">Shulga PM</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Volkova+AG%22">Volkova AG</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Primova+AA%22">Primova AA</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Remizova+YA%22">Remizova YA</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Meshkov+IO%22">Meshkov IO</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Kikot+AD%22">Kikot AD</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Tarasova+DA%22">Tarasova DA</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Bolashova+ES%22">Bolashova ES</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Ivashechkin+AA%22">Ivashechkin AA</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Makhotenko+AV%22">Makhotenko AV</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Snigir+EA%22">Snigir EA</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Masyukova+YA%22">Masyukova YA</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Radion+EI%22">Radion EI</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Kuznetsova+OA%22">Kuznetsova OA</searchLink>; Federal State Budgetary Institution 'NN Blokhin National Medical Research Center of Oncology', Ministry of Health of the Russian Federation (NN Blokhin NMRCO), Moscow 115478, Russia.<br /><searchLink fieldCode="AU" term="%22Cheporova+MS%22">Cheporova MS</searchLink>; Federal State Budgetary Institution 'NN Blokhin National Medical Research Center of Oncology', Ministry of Health of the Russian Federation (NN Blokhin NMRCO), Moscow 115478, Russia.<br /><searchLink fieldCode="AU" term="%22Fedyanin+MY%22">Fedyanin MY</searchLink>; Federal State Budgetary Institution 'NN Blokhin National Medical Research Center of Oncology', Ministry of Health of the Russian Federation (NN Blokhin NMRCO), Moscow 115478, Russia.<br /><searchLink fieldCode="AU" term="%22Tryakin+AA%22">Tryakin AA</searchLink>; Federal State Budgetary Institution 'NN Blokhin National Medical Research Center of Oncology', Ministry of Health of the Russian Federation (NN Blokhin NMRCO), Moscow 115478, Russia.<br /><searchLink fieldCode="AU" term="%22Makarov+VV%22">Makarov VV</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Yudin+VS%22">Yudin VS</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Keskinov+AA%22">Keskinov AA</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia.<br /><searchLink fieldCode="AU" term="%22Makarova+AS%22">Makarova AS</searchLink>; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks», Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 123182, Russia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101736595%22">Epigenomes</searchLink> [Epigenomes] 2026 Feb 12; Vol. 10 (1). <i>Date of Electronic Publication: </i>2026 Feb 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101736595 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2075-4655 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220754655%22">20754655 </searchLink><i>NLM ISO Abbreviation: </i>Epigenomes <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41718409 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/epigenomes10010011 Languages: – Code: eng Text: English Titles: – TitleFull: Analysis of HERV-K (HML2) Expression in Colorectal Cancer Samples. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Obrezanenko VS – PersonEntity: Name: NameFull: Shulga PM – PersonEntity: Name: NameFull: Volkova AG – PersonEntity: Name: NameFull: Primova AA – PersonEntity: Name: NameFull: Remizova YA – PersonEntity: Name: NameFull: Meshkov IO – PersonEntity: Name: NameFull: Kikot AD – PersonEntity: Name: NameFull: Tarasova DA – PersonEntity: Name: NameFull: Bolashova ES – PersonEntity: Name: NameFull: Ivashechkin AA – PersonEntity: Name: NameFull: Makhotenko AV – PersonEntity: Name: NameFull: Snigir EA – PersonEntity: Name: NameFull: Masyukova YA – PersonEntity: Name: NameFull: Radion EI – PersonEntity: Name: NameFull: Kuznetsova OA – PersonEntity: Name: NameFull: Cheporova MS – PersonEntity: Name: NameFull: Fedyanin MY – PersonEntity: Name: NameFull: Tryakin AA – PersonEntity: Name: NameFull: Makarov VV – PersonEntity: Name: NameFull: Yudin VS – PersonEntity: Name: NameFull: Keskinov AA – PersonEntity: Name: NameFull: Makarova AS IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 02 Text: 2026 Feb 12 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2075-4655 Numbering: – Type: volume Value: 10 – Type: issue Value: 1 Titles: – TitleFull: Epigenomes Type: main |
| ResultId | 1 |